Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Gossamer Bio Inc

GOSS
Current price
1.03 USD -0.04 USD (-3.74%)
Last closed 1.01 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 190 696 016 USD
Yield for 12 month -52.53 %
Week
Month
Year
GOSS
21.11.2021 - 28.11.2021

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Address: 3013 Science Park Road, San Diego, CA, United States, 92121

Analytics

WallStreet Target Price

5.47 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures GOSS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -187 299 008 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -35.2 %
PEG Ratio
Return On Equity TTM -232.88 %
Wall Street Target Price 5.47 USD
Revenue TTM
Book Value 0.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -1.6 USD
Diluted Eps TTM -1.6 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GOSS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GOSS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GOSS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.4828
Price Book MRQ 1.8616

Financials GOSS

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GOSS

For 52 weeks

0.45 USD 9.55 USD
50 Day MA 0.66 USD
Shares Short Prior Month 20 026 767
200 Day MA 1.12 USD
Short Ratio 8.7
Shares Short 22 158 451
Short Percent 11.55 %